Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).
Immune responses to Borrelia burgdorferi and their influence on spirochete transmission to Ixodes ricinus were analyzed in the natural European reservoir hosts; i.e., the mouse species Apodemus flavicollis (yellow-necked mouse) and Apodemus sylvaticus (wood mouse) and the vole species Clethrionomys glareolus (bank vole), and, in addition, in the laboratory mouse strain NMRI. Naive and preimmunized rodents were infected either by artificially infected I. ricinus larvae or by intradermal injection of spirochetes. Independent of the species, all animals developed antibodies to various spirochetal antigens. However, antibodies to the outer surface proteins A (OspA) and B (OspB) were not found in recipients infected via ticks. Rodents of the genus Apodemus and of the NMRI strain showed higher levels of B. burgdorferi-specific antibodies than those of the species C. glareolus. The rate of spirochete transmission to noninfected ticks correlated with both the quality and quantity of spirochete-specific antibodies generated in the various species: high levels of spirochete-specific immunoglobulins correlated with low transmission rates. Furthermore, lower transmission rates were observed with rodents expressing antibodies to OspA and OspB (i.e., intradermally infected or immunized) than with those lacking these specificities (i.e., infected via ticks). The study provides evidence that transmission of B. burgdorferi from natural hosts to ticks is controlled by the specificity and quantity of spirochete-reactive antibodies and suggests that immunity to B. burgdorferi in natural reservoir hosts is an important regulatory factor in the horizontal transmission of B. burgdorferi in nature.
Institute for Medical Parasitology, Bonn, Germany.
K
K
Kurtenbach
A
A
Dizij
H M
HM
Seitz
G
G
Margos
S E
SE
Moter
M D
MD
Kramer
R
R
Wallich
U E
UE
Schaible
M M
MM
Simon
D000818:Animals; D000830:Animals, Laboratory / Q000276:immunology; D000835:Animals, Wild / Q000276:immunology / Q000382:microbiology; D000907:Antibodies, Bacterial / Q000097:blood; D000917:Antibody Formation; D000942:Antigens, Bacterial; D000954:Antigens, Surface / Q000276:immunology; D003411:Arvicolinae / Q000276:immunology / Q000382:microbiology; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology; D001428:Bacterial Vaccines; D004197:Disease Reservoirs; D005060:Europe / Q000453:epidemiology; D016233:Immunotherapy, Active; D007303:Insect Vectors / Q000382:microbiology*; D008074:Lipoproteins; D008193:Lyme Disease / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control / Q000635:transmission; D009115:Muridae / Q000276:immunology* / Q000382:microbiology; D012376:Rodent Diseases / Q000453:epidemiology / Q000276:immunology* / Q000382:microbiology / Q000635:transmission; D013987:Ticks / Q000382:microbiology*
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; C072045:OspA protein; C077030:OspB protein, Borrelia burgdorferi